Delivery Order SPE2DB20D2014-SPE2DB25FC56F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $9,978.49. This non-set-aside, firm fixed-price contract is scheduled for completion by July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $12,410.16 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100 count) under a firm fixed price contract type. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive procurement. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $3,301.25 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, with an ultimate completion date of July 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 27 mg tablets (100-count) valued at $1,904.94 on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count supply) valued at $9,061.87 under a firm fixed price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $5,573.88. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order is issued as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER 36 mg tablets (100 count) with a ceiling value of $5,428.87. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $10,745.29 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply transaction fulfilling federal medical procurement requirements. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Concerta ER Tablets 27mg, with a ceiling value of $4,600.79 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The place of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC56FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,120.90 to AmerisourceBergen Drug Corp for Concerta ER 27 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for pharmaceutical supply across military healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, particularly the Department of Defense and military personnel. The company's comprehensive federal contract portfolio encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Through its expansive relationship with the DLA, AmerisourceBergen maintains capacity to deliver diverse pharmaceutical commodities to support military health operations globally, positioning this delivery order as part of its ongoing commitment to federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 7/25/25 |